We are shaping the future of stem cell therapies
Our platform removes unwanted cells, one of the major bottlenecks and risks in cell therapy manufacture.
Our platform removes unwanted cells, one of the major bottlenecks and risks in cell therapy manufacture.
Our flexible workflow seamlessly integrates with diverse starting materials in any laboratory setting—yours or ours.
We use cutting-edge design and manufacturing methods to produce a working product in just a few months.
Leaving no trace behind, our scalable process guarantees a safer, higher-quality product.
A seasoned bioinformatics specialist, Djordje combines his patient-centric industry knowledge with technical expertise and data-driven thinking to solve major challenges in stem cell therapies.
Mantas is an expert is synthetic biology and molecular cloning for advanced cell and gene therapies, having driven innovation in multiple biotech organisations, from startups to pharma.
Over a decade driving projects at leading PSC labs and biotechs has cemented Daniel as a world class stem cell biologist with deep knowledge of the challenges of cellular purity across many protocols.
Our board member Kerstin has extensive experience building, launching and supporting over a dozen biotechs in advanced cell and gene therapies.
Jonathan brings to our board his decades of industrial leadership experience in taking cell and gene therapies all the way to market.
A true pioneer and expert in the therapeutic cell manufacturing field, Ricardo combines extensive CMC and MSAT knowledge with quality and regulatory strategies.
As the former CEO of the Cell and Gene Therapy Catapult, Keith has been a driving force behind the development, commercialization and adoption of the cell and gene therapy industry across the UK.
